Medtronic Inc. (MDT) filed a Form 8K - Notice of Delisting or
Failure to Satisfy a Continued Listing Rule or Standard; Transfer
of Listing - with the U.S Securities and Exchange Commission on
January 26, 2015.
Prior to the Transactions, the Medtronic Common Shares were
registered pursuant to Section 12(b) of the Exchange Act and listed
on the NYSE under the symbol "MDT." As a result of the
Transactions, each Medtronic Common Share issued and outstanding
immediately prior to the effectiveness of the Merger, other than
Medtronic Common Shares held by Medtronic, was cancelled and
automatically converted into the right to receive one New Medtronic
ordinary share. Medtronic has requested that the NYSE file a Form
25 to withdraw the Medtronic Common Shares from listing and
terminate the registration of the Medtronic Common Shares under
Section 12(b) of the Exchange Act. Prior to the open of trading on
the NYSE on January 27, 2015, trading in the Medtronic Common
Shares will be suspended by the NYSE. Medtronic currently intends
to file a Form 15 with the SEC to terminate the registration of the
Medtronic Common Shares under the Exchange Act and suspend its
reporting obligations under Section 15(d) of the Exchange Act in
February 2015 or March 2015.
The information set forth in Item 2.01 of this Current Report on
Form 8-K is incorporated by reference into this Item 3.01.
The full text of this SEC filing can be retrieved at:
http://www.sec.gov/Archives/edgar/data/64670/000119312515020704/d860001d8k.htm
Any exhibits and associated documents for this SEC filing can be
retrieved at:
http://www.sec.gov/Archives/edgar/data/64670/000119312515020704/0001193125-15-020704-index.htm
Public companies must file a Form 8-K, or current report, with
the SEC generally within four days of any event that could
materially affect a company's financial position or the value of
its shares.
Subscribe to WSJ: http://online.wsj.com?mod=djnwires